Skip to main content

Advertisement

Log in

Association of tumor-associated fibroblasts with progression of hepatocellular carcinoma

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Interaction between tumor and stromal cells plays an important role in cancer progression. The aim of this study was to explore the effects of tumor-associated fibroblasts on regulation of hepatocellular carcinoma (HCC) progression. Sixty-five cases of HCC and the corresponding normal liver tissues were recruited for immunohistochemical assessment of α-smooth muscle actin (α-SMA) expression, a biomarker for activated fibroblasts. Clinicopathological data were also collected from HCC patients for association with α-SMA expression. Primary cell culture of fibroblasts from HCC tissues was used to generate conditioned medium for testing the effect on regulation of HCC cell migration capacity in the transwell cell migration assay. α-SMA protein was expressed in 84.0 % (21 out 25 cases) of the fibroblasts from the metastatic HCCs, 45 % (18/40) from HCCs without metastasis, and 19.2 % (5/26) from normal liver tissues, difference of which was statistically significant (P < 0.01). The expression of α-SMA protein in HCC tissues was associated with tumor thrombosis, poor pathology grade, advanced clinical stages, and lymph node metastasis. The conditioned medium from the primary cultured fibroblasts with α-SMA expression significantly promoted the migration capacity of HCC Hep3B cells compared to the heat-inactivated conditioned medium. The data from the current study demonstrated that expression of α-SMA protein in HCC fibroblasts associated with tumor metastasis and advanced clinical stages and that the conditioned medium from α-SMA-positive fibroblasts enhanced HCC cell migration. This study indicates that α-SMA protein might serve as a biomarker to predict HCC progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Cucchetti A, Piscaglia F, Caturelli E, et al. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol. 2009;16(2):413–22.

    Article  PubMed  Google Scholar 

  2. Tsochatzis EA, Meyer T, Burroughs AK. Hepatocellular carcinoma. N Engl J Med. 2012;366(1):1118–27.

    Google Scholar 

  3. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6(9):674–87.

    Article  PubMed  CAS  Google Scholar 

  4. Tang ZY, Ye SL, Liu YK, et al. Adecade’s studies on metasis. Cancer Res Clin Oncol. 2004;130(4):187.

    Article  Google Scholar 

  5. Rubin H. Selected cell and selective microenvironment in neoplastic differentiation: implications for tumor development. Cancer Res. 2001;61(3):799–807.

    PubMed  CAS  Google Scholar 

  6. Mueller MM, Fusenig NE. Friends or does bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 2004;4(11):839–49.

    Article  PubMed  CAS  Google Scholar 

  7. Mbeunkui F, Johann DJ Jr. Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol. 2009;63(4):571–82.

    Article  PubMed  Google Scholar 

  8. Daniele C, Antonio PB, Alessandra P, et al. Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer. Int J Hepatol. 2011;2011:120925.

    Google Scholar 

  9. Omar EF, Aubie KS, Douglas WS, Simon WH. Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol. 2010;21(1):33–9.

    Article  Google Scholar 

  10. Sirica AE, Campbell DJ, Dumur CI. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol. 2011;27(3):276–84.

    Article  PubMed  CAS  Google Scholar 

  11. Tomasek JJ, Gabbiani G, Hinz B, et al. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349–63.

    Article  PubMed  CAS  Google Scholar 

  12. Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P, Rosenbaum J. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology. 1997;26(6):1458–66.

    Article  PubMed  CAS  Google Scholar 

  13. Friedman SL, Rockey DC, McGuire RF, Maher JJ, Boyles JK, Yamasaki G. Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology. 1992;15(2):234–43.

    Article  PubMed  CAS  Google Scholar 

  14. Ronnov-Jessen L, Van Deurs B, Nielsen M, Petersen OW. Identification, paracrine generation, and possible function of human breast carcinoma myofibroblasts in culture. In Vitro Cell Dev Biol. 1992;28(4):273–83.

    Article  Google Scholar 

  15. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392–401.

    Article  PubMed  CAS  Google Scholar 

  16. Liang P, Hong JW, Ubukata H, et al. Myofibroblasts correlate with lymphatic microvessel density and lymph node metastasis in early-stage invasive colorectal carcinoma. Anticancer Res. 2005;25(4):2705–12.

    PubMed  Google Scholar 

  17. Kellerman MG, Sobral LM, Dasilva SD, et al. Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell prolifer action. Oral Oncol. 2007;44(5):509–17.

    Article  Google Scholar 

  18. Parrott JA, Nilsson E, Mosher R, et al. Stromal-epithelial interactions in the progression of ovarian cancer, influence and source of tumor stromal cells. Mol Cell Endocrinol. 2001;175(1–2):29–39.

    Article  PubMed  CAS  Google Scholar 

  19. Casey TM, Eneman J, Crocker A, et al. Cancer associated fibroblasts stimulated by transforming growth factor beta (TGF-beta1) increase invasion rate of tumor cells: a population study. Breast Cancer Res Treat. 2008;110(1):39–49.

    Article  PubMed  CAS  Google Scholar 

  20. Schor SL, Schor AM. Phenotypic and genetic alterations in mammary stroma: implications for tumor progression. Breast Cancer Res. 2001;3(6):373–9.

    Article  PubMed  CAS  Google Scholar 

  21. Lokeshwar VB, Rubinowicz D, Schroeder GL, et al. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J Biol Chem. 2001;276(15):11922–32.

    Article  PubMed  CAS  Google Scholar 

  22. Siddiq F, Sarkar FH, Wali A, et al. Increased osteonectin expression is associated with malignant transformation and tumor associated fibrosis in the lung. Lung Cancer. 2004;45(2):197–205.

    Article  PubMed  Google Scholar 

  23. Sieuwerts AM, Klijn JG, Foekens JA. Insulin-like growth factor 1 (IGF-1) and urokinase-type plasminogen activator (uPA) are inversely related in human breast fibroblasts. Mol Cell Endocrinol. 1999;154(1–2):179–85.

    Article  PubMed  CAS  Google Scholar 

  24. Wang CS, Têtu B. Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction. Int J Cancer. 2002;99(6):792–9.

    Article  PubMed  CAS  Google Scholar 

  25. Lee J, Fassnacht M, Nair S, et al. Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts. Cancer Res. 2005;65(23):11156–63.

    Article  PubMed  CAS  Google Scholar 

  26. De Wever O, Nguyen QD, Van Hoorde L, et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J. 2004;18(9):1016–8.

    PubMed  Google Scholar 

  27. Stuelten CH, DaCosta Byfield S, Arany PR, et al. Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta. J Cell Sci. 2005;118(Pt 10):2143–53.

    Article  PubMed  CAS  Google Scholar 

  28. Tuxhorn JA, Ayala GE, Smith MJ, et al. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res. 2002;8(9):2912–23.

    PubMed  CAS  Google Scholar 

  29. Yang F, Tuxhorn JA, Ressler SJ, et al. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 2005;65(19):8887–95.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported in part by a grant from the National Science and Technology Foundation of China (#2008ZX10002-025).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Feng Shen.

Additional information

Xiao-Yu Yang and Dong Zhang have contributed equally to this study. And both of them are first authors of this paper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, XY., Zhang, D., Zou, QF. et al. Association of tumor-associated fibroblasts with progression of hepatocellular carcinoma. Med Oncol 30, 593 (2013). https://doi.org/10.1007/s12032-013-0593-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0593-9

Keywords

Navigation